DataMeds AI, Inc.

Name: DataMeds AI, Inc. standardized financial statements, quarterly
Creator: Listed

MEDSNasdaqCIK 2030763Consumer discretionaryFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.8m, Q2 FY2026

Operating income−$7.3m, Q2 FY2026

Net income−$18.4m, Q2 FY2026

DataMeds AI, Inc., income statement, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	not reported	0.0	5.7	12.4	10.9	7.8	3.0	1.7	1.6	1.8
Cost of revenue	$m	not reported	0.0	5.2	11.2	10.2	7.3	2.8	9.5	1.4	1.6
Gross profit	$m	not reported	(0.0)	0.5	1.2	0.7	0.5	0.2	(7.9)	0.2	0.2
Operating income	$m	(0.1)	(0.6)	(1.7)	(3.7)	(31.3)	(5.5)	(31.5)	(25.4)	(6.0)	(7.3)
Interest expense	$m	0.0	0.0	0.1	0.7	1.1	1.2	1.4	0.9	2.1	1.6
Net income	$m	(0.1)	(0.6)	(1.9)	(4.3)	(32.4)	(6.7)	(34.3)	(27.9)	(7.7)	(18.4)
Diluted EPS	$ per share	0.00	(0.01)	(0.04)	not reported	(0.62)	(5.40)	(0.46)	not reported	(0.07)	(7.13)
Basic EPS	$ per share	0.00	(0.01)	(0.04)	not reported	(0.62)	(5.40)	(0.46)	not reported	(0.07)	(7.13)

Balance sheet

Cash and equivalents$2.5m, Q2 FY2026

Long-term debt$12.6m, Q2 FY2026

Shareholders' equity−$19.5m, Q2 FY2026

DataMeds AI, Inc., balance sheet, quarterly
Line item	Unit	period not labelled2022-12-31	period not labelled2023-12-31	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	not reported	0.0	not reported	not reported	not reported	1.0	2.5	0.4	4.2	0.0	0.1	2.5
Current assets	$m	not reported	0.3	not reported	not reported	not reported	15.2	16.6	13.5	12.8	2.8	2.8	5.6
Total assets	$m	not reported	0.3	not reported	not reported	not reported	57.3	58.1	54.2	52.8	30.5	30.1	32.8
Current liabilities	$m	not reported	2.9	not reported	not reported	not reported	38.0	46.2	42.4	32.7	29.8	32.2	39.4
Total liabilities	$m	not reported	3.2	not reported	not reported	not reported	50.6	53.6	53.3	46.0	42.9	45.2	52.3
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	11.5	24.1	10.1	12.6	12.6	12.6	12.6
Current portion of debt	$m	not reported	0.4	not reported	not reported	not reported	11.5	6.4	13.2	12.2	10.9	15.2	19.2
Shareholders' equity	$m	(0.0)	(2.9)	(3.0)	(3.1)	10.0	6.7	4.5	0.9	6.8	(12.4)	(15.1)	(19.5)

Cash flow

Operating cash flow−$2.9m, Q2 FY2026

DataMeds AI, Inc., cash flow, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	31.2	330	1,038	(2,624)	(1,347)	(2,079)	(1,135)	(6,293)	(3,413)	(2,894)

Diluted shares (weighted)2.57m, Q2 FY2026

DataMeds AI, Inc., shares, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	44.7	45.9	48.4	51.9	1.2	74.4	105	2.6

Shares outstanding: 3.06m at Aug 17, 2026, from the cover of the 10-Q filed Aug 17, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.